F-group (family)
206.1.1.73 Pkinase, APH
Ligands and drugs
571
Member domains
493
with ligand contacts (≤ 4 Å)
86.3% of members
367
with DrugDomain annotations
64.3% of members
297
with a DrugBank compound
52.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 206.1.1.73 belongs to X-group 206 Protein kinase/SAICAR synthase/ATP-grasp, which binds 10.2 ligand superclasses per 20 proteins, broader than 96% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00171 | ATP | ATP | 22 |
| DB16833 | ADP | Adenosine disphosphate | 21 |
| DB14981 | IHP | Phytic acid | 8 |
| DB00627 | NIO | Niacin | 7 |
| DB06832 | 041 | Prinaberel | 6 |
| DB15408 | 3NG | Silmitasertib | 6 |
| DB07715 | EMO | Emodin | 5 |
| DB00131 | AMP | Adenosine phosphate | 3 |
| DB03793 | BEZ | Benzoic acid | 3 |
| DB08660 | TXQ | Quinalizarin | 3 |
| DB03909 | ACP | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 2 |
| DB04462 | TBS | Tetrabromo-2-Benzotriazole | 2 |
| DB07546 | CCK | [1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid | 2 |
| DB07767 | FER | Ferulic acid | 2 |
| DB08473 | RFZ | Dichlororibofuranosylbenzimidazole | 2 |
| DB12010 | — | Fostamatinib | 2 |
| DB01765 | — | (5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid | 1 |
| DB02054 | GAB | Gabaculine | 1 |
| DB02170 | — | 1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One | 1 |
| DB02656 | LY2 | LY-294002 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 70 |
| MGmetal | MAGNESIUM ION | 29 |
| NAmetal | SODIUM ION | 26 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 25 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 22 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 17 |
| NIO | NICOTINIC ACID | 15 |
| E3U | (6aR)-3,4,6a,10-tetrakis(oxidanyl)-6,7-dihydroindeno[2,1-c]chromen-9-one | 9 |
| 3NG | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | 7 |
| 041 | 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL | 6 |
| 42J | 2-(3,4-dichlorophenyl)ethanamine | 6 |
| 54G | 2-hydroxy-5-methylbenzoic acid | 6 |
| 4B0 | 3-(4,5,6,7-tetrabromo-1H-benzotriazol-1-yl)propan-1-ol | 5 |
| 7FC | 4-[6,8-bis(chloranyl)-3-oxidanyl-4-oxidanylidene-chromen-2-yl]benzoic acid | 5 |
| 7M0 | 5,6-DIBROMOBENZOTRIAZOLE | 5 |
| 9YE | 4-(3-methylbut-2-enoxy)-5-propan-2-yl-7,8-dihydro-6~{H}-indeno[1,2-b]indole-9,10-dione | 5 |
| EMO | 3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE | 5 |
| FXB | 5-propan-2-yl-4-prop-2-enoxy-7,8-dihydro-6~{H}-indeno[1,2-b]indole-9,10-dione | 5 |
| 54R | N-(3-{[(2-chlorobiphenyl-4-yl)methyl]amino}propyl)acetamide | 4 |
| 551 | methyl 3-[(3-{[(2-chlorobiphenyl-4-yl)methyl]amino}propyl)amino]-3-oxopropanoate | 4 |